Bethesda, MD, United States of America

Renqiu Hu

This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renqiu Hu. Retrieved from https://idiyas.com/inventor/renqiu-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Renqiu Hu: Innovator in Interferon Research

Introduction

Renqiu Hu is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of hybrid human interferon polypeptides. His work has implications for treating viral diseases and regulating cell growth.

Latest Patents

Renqiu Hu holds 2 patents related to his research. His latest patents include "Interferon alpha hybrids," which disclose hybrid human interferon-α polypeptides and the corresponding nucleic acid molecules. These patents also cover pharmaceutical compositions comprising these peptides and their use in treating viral diseases and regulating cell growth. Another patent, "Interferon α hybrids," similarly focuses on hybrid human interferon-α polypeptides and their applications in medicine.

Career Highlights

Renqiu Hu works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization highlights his commitment to advancing public health through innovative research.

Collaborations

Some of his notable coworkers include Mark P Hayes and Kathryn C Zoon. Their collaboration in research projects has contributed to the advancement of knowledge in the field of interferon research.

Conclusion

Renqiu Hu's innovative work in the development of hybrid human interferon polypeptides showcases his dedication to improving healthcare solutions. His patents reflect a significant step forward in the treatment of viral diseases and cell growth regulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…